CoFlo Medical
San Francisco, US · Founded 2022 · Delaware corporation
Find your way into CoFlo Medical
Sign up to see every warm intro you have to CoFlo Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoFlo Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CoFlo Medical develops a drug-delivery platform based on core annular flow, which surrounds a viscous drug with a thin low-viscosity fluid so ultra-high-concentration biologics can be injected through fine needles at low force. Its CO-AXL hub adapts any primary container to enable at-home injection of highly viscous formulations (up to 400 mg/mL and over 1,000 cP), serving pharmaceutical developers and patients.
Founders & leadership
CoFlo Medical was founded in 2022 by Kripa Varanasi, Simon Rufer, and Vishnu Jayaprakash.

Board
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2025
▶$500KraisedNov 2025 · 1 investors · BiotechnologyRule 506(b)
- Matthew GoldmanDirector
- Kripa VaranasiDirector
- Simon RuferExecutive Officer, Director
- Vishnu JayaprakashExecutive Officer
- Offering amount
- $6M
- Amount sold
- $500K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as CoFlo Medical.
Frequently asked questions
- What does CoFlo Medical do?
- CoFlo Medical develops a drug-delivery platform based on core annular flow, which surrounds a viscous drug with a thin low-viscosity fluid so ultra-high-concentration biologics can be injected through fine needles at low force. Its CO-AXL hub adapts any primary container to enable at-home injection of highly viscous formulations (up to 400 mg/mL and over 1,000 cP), serving pharmaceutical developers and patients.
- Who founded CoFlo Medical?
- CoFlo Medical was founded by Kripa Varanasi, Simon Rufer, Vishnu Jayaprakash in 2022.
- How much funding has CoFlo Medical raised?
- CoFlo Medical has disclosed $500K raised across 1 round.
- Where is CoFlo Medical headquartered?
- CoFlo Medical is headquartered in San Francisco, US.


